Real World Evidence Lead β€” Hybrid, Rare-Disease Impact

Real World Evidence Lead β€” Hybrid, Rare-Disease Impact

Full-Time 60000 - 80000 Β£ / year (est.) No working from home possible
BIOMARIN

At a Glance

  • Tasks: Lead real-world evidence generation and observational studies in the rare disease sector.
  • Company: Join BioMarin, a leader in innovative therapies for rare diseases.
  • Benefits: Enjoy a hybrid work model, competitive salary, and opportunities for professional growth.
  • Other info: Collaborate with external partners and engage with regulatory authorities.
  • Why this job: Make a significant impact on patient care through strategic evidence generation.
  • Qualifications: PhD in Epidemiology or related field with experience in the pharmaceutical industry.

The predicted salary is between 60000 - 80000 Β£ per year.

BioMarin in London is looking for a Real World Evidence Lead to strategize real-world evidence generation and lead observational studies. This hybrid role requires experience in the pharmaceutical industry and a doctoral degree in Epidemiology or related field.

You'll be crucial in driving clinical adoption and collaborating with external partners. Successful candidates will have demonstrated leadership in pharmacoepidemiology and the capacity to engage with regulatory authorities effectively.

Real World Evidence Lead β€” Hybrid, Rare-Disease Impact employer: BIOMARIN

BioMarin is an exceptional employer that fosters a collaborative and innovative work culture, particularly in the vibrant city of London. With a strong emphasis on employee growth and development, we offer unique opportunities for mentorship and leadership within the field of clinical development. Our hybrid work model ensures a balanced approach to work-life integration, making BioMarin a rewarding place for professionals seeking to make a meaningful impact in the biopharmaceutical industry.

BIOMARIN

Contact Details:

BIOMARIN Recruitment Team

We think you need these skills to ace Real World Evidence Lead β€” Hybrid, Rare-Disease Impact

Real World Evidence Generation
Observational Studies
Pharmaceutical Industry Experience
Doctoral Degree in Epidemiology
Leadership in Pharmacoepidemiology
Engagement with Regulatory Authorities
Strategic Thinking